Dr. Mercola's Censored Library (Private Membership)

Share this post

Ivermectin vs. Merck's New Antiviral, Molnupiravir

takecontrol.substack.com

Ivermectin vs. Merck's New Antiviral, Molnupiravir

Based on Merck's data, a comparison between molnupiravir and ivermectin yields interesting results. Consider other nonprescription strategies for prevention and early treatment.

Dr. Joseph Mercola
Oct 25, 2021
∙ Paid
4
Share this post

Ivermectin vs. Merck's New Antiviral, Molnupiravir

takecontrol.substack.com
Share

Keep reading with a 7-day free trial

Subscribe to

Dr. Mercola's Censored Library (Private Membership)
to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Dr. Joseph Mercola
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing